✦ LIBER ✦

Efficacy of butyrate in the treatment of mild to moderate Crohn's disease

✍ Scribed by A. Di Sabatino; P. Cazzola; R. Ciccocioppo; R. Morera; P. Biancheri; L. Rovedatti; L. Cantoro; A. Vanoli; F.P. Tinozzi; S. Tinozzi; G.R. Corazza

Book ID: 118648851
Publisher: Elsevier
Year: 2007
Tongue: English
Weight: 121 KB
Volume: 1
Category: Article
ISSN: 1594-5804
DOI: 10.1016/s1594-5804(08)60009-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evidence-based treatment algorithm for m

Evidence-based treatment algorithm for mild to moderate Crohn's disease

✍ William J Sandborn 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 74 KB

The burden of illness in mild to moderat

The burden of illness in mild to moderate Crohn's disease

✍ Sandra Joshua-Gotlib; Karin Coyne; Mervyn Danilewitz; Miriam Kimel; Christine Th 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Budesonide modified release capsules as

Budesonide modified release capsules as maintenance treatment in mild to moderate Crohn’s disease

✍ S.B. Hanauer; W.J. Sandborn; J.G. Levine; A. Persson; T. Persson 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 27 KB

Recombinant Human Interleukin 10 in the

Recombinant Human Interleukin 10 in the Treatment of Patients With Mild to Moderately Active Crohn's Disease

✍ Richard N. Fedorak*; Alfred Gangl†; Charles O. Elson§; Paul Rutgeerts‖; Stefan S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Crohn's is not a 6-week disease. Lifelon

Crohn's is not a 6-week disease. Lifelong management of mild to moderate Crohn's disease

✍ Gary R. Lichtenstein; Stephen B. Hanauer; Sunanda V. Kane; Daniel H. Present 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Nicergoline in the Treatment of Mild- to

Nicergoline in the Treatment of Mild- to- Moderate Alzheimer's Disease

✍ Bengt Winblad, M. Luisa Bonura, Bianca M. Rossini, Dr Angelo Battaglia 📂 Article 📅 2001 🏛 Springer International Publishing AG 🌐 English ⚖ 241 KB